Tag Archives: The Hill

Cancer Docs Weigh in on Medicare Part B Demo

medical_research

This week, American Society of Clinical Oncology (ASCO) President Daniel Hayes, MD and CEO Clifford Hudis, MD shared their thoughts in The Hill on how “We can do better than Medicare Part B demo.” At the forefront of oncology, they remind us that we are living in remarkable times of real progress – treatment options are ever-improving as is the number of cancer survivors. However, the experimental nature of Medicare Part B demo poses a Read More >

Health  |  Leave a comment  |  Email This Post
Tags: , , , , , , ,

NORD President: Congress must act now to help 15 million sick children

lab_tech

Writing in The Hill, National Organization for Rare Disorders (NORD) President and CEO Peter Saltonstall called upon Congress to act swiftly to maintain an important program encouraging research into treatments for rare pediatric diseases. The Rare Pediatric Priority Review Voucher (PRV) Program is set to expire at the end of the month, unless Congress reauthorizes it. Saltonstall writes: Developing therapies for people with rare diseases is incredibly difficult. Rare diseases are scientifically and medically complex, Read More >

Health, Public Policy  |  Leave a comment  |  Email This Post
Tags: , , , , , , , ,

The Hill’s Congress Blog: Innovation in medicine isn’t optional – it’s imperative

TheHill

Earlier this week, The Hill’s Congress Blog posted an op-ed penned by Andrew von Eschenbach and Paul Howard entitled, “Innovation in medicine isn’t optional – it’s imperative” highlighting the importance of encouraging innovation and preserving incentives for drug development. The authors recommend increased cooperation and collaboration between industry, academia, and regulators, in addition to recognition by the federal government that ‘a vibrant life-sciences industry will generate higher national productivity, lower total health care costs, and Read More >

Business and Investments, Health  |  Leave a comment  |  Email This Post
Tags: , , , , ,